Oct 16, 2025
Repaglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus. The average market price for this medicine normally hovers around the £5 mark but in late 2019 the drug tariff started to come down from over £10.42...
Sep 16, 2025
Leslie Galloway, EMIG Chairman, shared his analysis of VPAG. Here’s Charles’ key takeaways: · The NHS VPAG rebate is £1bn over 3 years and so is a fixed rebate with risk share. · Global Pharma CEOs have asked for lower rebates and a better deal, that...
Sep 16, 2025
Charles Joynson, WaveData MD, decided to have a look at the differences between the average market price for generics and the English drug tariff. He wanted to know if the gap between the two was being squeezed, resulting in some of the misery pharmacists are going...
Sep 16, 2025
Four times over the last 10 years, free market competition between the manufacturers of Olanzapine tablets drove the price to a level where profit was impossible and withdrawal is the only option. When prices decline in the market, the reimbursement drug tariff often...
Aug 22, 2025
Check out the latest UK Price Watch article in the Generics Bulletin for analysis and insight on May’s product launches, the biggest risers, the biggest fallers and the fastest movers…. with market data provided by WaveData. Dave Wallace editor at Generics Bulletin,...
Aug 5, 2025
Between 2001 and 2022 the number of generics in the English drug tariff increased from 1682 to 3955. Most of this was driven by increased patient demand and new product launches to cope with this demand. However, more recently the number of products in this...
